Drug Development Pharma - August 13, 2015
New vaccine against Ebola virus
The Research Council of Norway’s Programme for Global Health and Vaccination Research (GLOBVAC) is co-funding testing of a new vaccine against Ebola. Preliminary results from the Norwegian-led trial underway in Guinea, published in the medical journal The Lancet, indicate that the vaccine may provide complete protection against Ebola virus disease. The vaccine study is a […]
Uncategorized - February 12, 2015
Simpler Ebola Test in Works
A new Ebola test under development by a team of European scientists will make it possible to screen people where they live–eliminating the risk of infection during a long ambulance journey to a field hospital. “If you don’t already have Ebola, then you’re certain to have caught it after a trip in the ambulance,” says […]
Uncategorized - January 5, 2015
Salts, Fluids Could Save Ebola Patients
Many Ebola patients in Africa could be saved if they were infused with salts and fluids, said Professor Anders Perner of Copenhagen University Hospital, Rigshospitalet, in an article in the Lancet. “It has taken us too long to acknowledge that we could save a lot of lives in West Africa by very simple means,” says […]
Clinical Trials - December 8, 2014
Bavarian Nordic vs Ebola
Denmark’s Bavarian Nordic announced Dec. 4 that a first subject has been dosed with MVA-BN Filo in a Phase 1 safety and immunogenicity trial, evaluating a heterologous prime-boost regimen of Ebola candidate vaccines. The trial, sponsored by the University of Oxford, is assessing the monovalent cAd3-EBO Z vaccine co-developed by GSK and the U.S. National […]
Drug Development Pharma - November 11, 2014
Ebola Drug Nears Approval
An influenza drug created by Japan’s Fujifilm Holding Corp. could be approved to treat Ebola by the end of this year. The drug, Avigan, already has been used in Norway, France, Germany and Spain to treat Ebola patients. It was approved in Japan earlier this year to counter new forms of influenza. “So far, four […]
Clinical Trials - November 4, 2014
Ebola Nasal Vaccine Trials
Researchers at the University of Texas at Austin have a nasal vaccine for the Ebola virus in development that has provided long-term protection for non-human primates against the virus. Small pre-clinical study results are the first to show that a single dose of a non-injectable vaccine for Ebola could have a longer duration. The research […]
